Department of Family Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.
Int J Environ Res Public Health. 2021 Jun 10;18(12):6295. doi: 10.3390/ijerph18126295.
Mastalgia, or breast pain, is common among women which can lead to significant impairment in daily living. Hence, finding an effective treatment that can alleviate the symptom is very important. Thus, we carry out this study to determine the efficacy of evening primrose oil (EPO) for mastalgia treatment in women. The review included published randomised clinical trials that evaluated EPO used for treating mastalgia against a placebo or other treatments, irrespective of the blinding procedure, publication status, or sample size. Two independent authors screened the titles and abstracts of the identified trials; full texts of relevant trials were evaluated for eligibility. Two reviewers independently extracted data on the methods, interventions, outcomes, and risk of bias. The random-effects model was used for estimating the risk ratios and mean differences with 95% confidence intervals. Thirteen trials with 1752 randomised patients were included. The results showed that EPO has no difference to reduce breast pain compared to topical NSAIDS, danazol, or vitamin E. The number of patients who achieved pain relief was no different compared to the placebo or other treatments. The EPO does not increase adverse events, such as nausea, abdominal bloating, headache or giddiness, increase weight gain, and altered taste compared to a placebo or other treatments. EPO is a safe medication with similar efficacy for pain control in women with mastalgia compared to a placebo, topical NSAIDS, danazol, or vitamin E.
乳房痛,或乳房疼痛,在女性中很常见,可导致日常生活明显受损。因此,找到一种有效的治疗方法来缓解症状非常重要。因此,我们进行这项研究来确定月见草油(EPO)治疗女性乳房痛的疗效。综述包括已发表的随机临床试验,评估了 EPO 治疗乳房痛的疗效,与安慰剂或其他治疗方法(无论盲法程序、发表状态或样本量如何)进行比较。两名独立作者筛选了已确定试验的标题和摘要;评估了相关试验的全文,以确定其纳入的标准。两名审查者独立提取了方法、干预措施、结局和偏倚风险的数据。使用随机效应模型估计风险比和均值差异及其 95%置信区间。纳入了 13 项试验,共 1752 名随机患者。结果表明,EPO 与局部 NSAIDs、丹那唑或维生素 E 相比,对减轻乳房疼痛没有差异。与安慰剂或其他治疗方法相比,达到疼痛缓解的患者人数没有差异。EPO 与安慰剂或其他治疗方法相比,不会增加不良反应,如恶心、腹胀、头痛或头晕、体重增加和味觉改变。EPO 是一种安全的药物,与安慰剂、局部 NSAIDs、丹那唑或维生素 E 相比,在控制女性乳房痛方面具有相似的疗效。